Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1063 of 1,261
  1. US 7355079

    Thyronamine derivatives and analogs and methods of use thereof

    The Regents of the University of California · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  2. US 7354900

    Treatment and inhibition of ocular infections and wounds by CAP37 and CAP37 peptides

    The Board of Regents of the University of Oklahoma · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  3. US 7353829

    Methods and apparatus for multi-photon photo-activation of therapeutic agents

    Provectus Devicetech, Inc. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  4. US 7354576

    Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidase

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  5. US 7354578

    Method of tumor regression with VEGF inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  6. US 7354579

    Method of treating cancer with a VEGF antagonist and an anti-proliferative agent

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  7. US 7354580

    Method of administering and using VEGF inhibitors for the treatment of human cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  8. US 7354711

    Methods for inhibiting immunostimulatory DNA associated responses

    The Department of Veterans Affairs, as represented by the Secretary of United States of America · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  9. US 7354761

    Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs

    The Regents of the University of California · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  10. US 7354904

    Bacteriocin inducer peptides

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  11. US 7354582

    Use of VEGF antagonists for the treatment of malignant gliomas

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  12. US 7354894

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  13. US 7351411

    Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF)

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted
  14. US 7351408

    Glycoconjugates and methods

    The Regents of the University of California · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted
  15. US 7351403

    Sunscreen reagents from unsaturated waxes and triglycerides

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted
  16. US 7351542

    Methods of modulating tubulin deacetylase activity

    The Regents of the University of California · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted
  17. US 7351718

    Substituted pyrrolidine and related compounds

    Theravance, Inc. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted
  18. US 7351704

    Indazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted
  19. US 7351827

    Substituted oxetanes, method of making, and method of use thereof

    UNIVERSITY OF CONNECTICUT · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted
  20. US 7351717

    Substituted pyrrolidine and related compounds

    Theravance, Inc. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted
  21. US 7351739

    Bioactive compounds and methods of uses thereof

    Regents of the University of Minnesota · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted
  22. US 7351791

    Intermediate for preparing glycopeptide derivatives

    Theravance, Inc. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted
  23. US 7351691

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted
  24. US 7351707

    Spiroazacyclic compounds as monoamine receptor modulators

    ACADIA Pharmaceuticals Inc. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.